{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-dominant-optic-atrophy-plus","columns":[{"gene":"","key":"population-3abb8c6fa526ba0853a5","label":"Autosomal dominant optic atrophy plus syndrome","mondoId":"MONDO:0014720","onsetQualifier":null,"originColumnKey":"MONDO:0014720/ORPHA:1215","originalViews":[{"key":"MONDO:0014720/ORPHA:1215","label":"Autosomal dominant optic atrophy plus syndrome","scopeLabel":"ORPHA:1215","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0473c1ec178f4e1b1737b4d33b59711663fd806ad910c63b13e854e1235bad36","0e61860dfe83083f278e949c416cb8ee12c52e774418a45edd9983a914770327","27b3707c21fd531cc407239943fe1c76a9b407ce5b6fc4e93d09f1a6d7f2c789","33a364533972607574ab8e1c0d220b3fc8331a63b81acadcc81622e3e160c494","350526a4dbef0804268536a2f35fbafa70b84ccba9c959f64966187f06ceb405","367c6f0fcc55f6dc083222ffdb3ecd244359e85e3f885b2afce26d3170a1063f","3bbf5c08c123e7df149a9bae91fb04ecc696ec28d43c3fdb13042713ffb954df","40994de43315357426542f1df37f9708ae171420da4b27520b6d05c2557762b2","4631bd238b65c244d4ef71dcac96f2df0e8f826834cb117fdb59c0902106fb0a","4aa5a09fa569fe4a52fc1bf45346456698f5dc4f8c796962c28bb5e52a2819b8","54d10b2a3caaccb62948533bd9726fb01a918ad248bc4943059e8afa74212ca2","5b5d78112382431b5a12f210bad6d8de86b6ae63ee80fc96de72fbe309809211","6691323d105999ab47c5c34af8d860fc12de29b5b14b0c04d14bbe99d9128c5a","6a042c6c9a89b789161bba2a282d406bcec187a87d62d044010b9d60f4cc2341","6f132c57cc40b31b032269b3940ad3c3dd5f80f46c4f387002801976b1251de2","76a1d604409dd78b85653d41e0c0cd03befdea15d73b5e7408bc8f79e03f9bbf","77b7b7b86f94088c3ab3c4ead467d40a7efb71072fd0137eaaa7e0d848fb6c8f","adc9fe72e50441de8770f39e8420b6feadcfc202668de86270331dab4f85ab2a","af354b8e08cc79c2a8072eb517859e3c8f5549c40878763e5d3ba8f084806643","b5b41ee4361cbb9d919eadab81b8c1bb3e2305296733cd46af0443a62f59e431","bc0e68b6e878be5e888ed0e1a6069e24d9cbed96c45ca2716d63bc47687ce96e","be5675860649520d345f447adec2ec43c1e035921bf08b34e83a1adaeadfb149","c49669daa48f65138a7cbc2fe1c82adf4fd05bb2696bc0ed09db78d0274d26fa","c991b5091478b9fa0d1616921d2ccc751c4a865f443113954593af279d35ba75","f337aff3f68b7ff908ad02bee155635bdb68deb9c8fa84ed7441d2caa6e5d6f2","f55e760c03b5b1e34ccfb2b8f9eaf3367a9cf0f5cb22572db6b5941debbfa444"],"recordQualifiers":{},"scopeLabel":"ORPHA:1215","sourceIds":["ORPHA:1215"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-3abb8c6fa526ba0853a5"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0020119","HP:0000649","HP:0003438","HP:0004463","HP:0001251","HP:0001488","HP:0001638"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":26,"sourceGroups":{"orphanet":26}},"features":[{"hpoId":"HP:0020119","label":"Abnormal retinal nerve fiber layer morphology","primary":true},{"hpoId":"HP:0000649","label":"Abnormality of visual evoked potentials","primary":true},{"hpoId":"HP:0003438","label":"Absent Achilles reflex","primary":true},{"hpoId":"HP:0004463","label":"Absent brainstem auditory responses","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0001488","label":"Bilateral ptosis","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":true},{"hpoId":"HP:0001133","label":"Constriction of peripheral visual field","primary":false},{"hpoId":"HP:0000819","label":"Diabetes mellitus","primary":false},{"hpoId":"HP:0003444","label":"EMG: chronic denervation signs","primary":false},{"hpoId":"HP:0100285","label":"EMG: impaired neuromuscular transmission","primary":false},{"hpoId":"HP:0012378","label":"Fatigue","primary":false},{"hpoId":"HP:0003325","label":"Limb-girdle muscle weakness","primary":false},{"hpoId":"HP:0002076","label":"Migraine","primary":false},{"hpoId":"HP:0003737","label":"Mitochondrial myopathy","primary":false},{"hpoId":"HP:0007002","label":"Motor axonal neuropathy","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0001761","label":"Pes cavus","primary":false},{"hpoId":"HP:0000590","label":"Progressive external ophthalmoplegia","primary":false},{"hpoId":"HP:0000529","label":"Progressive visual loss","primary":false},{"hpoId":"HP:0000407","label":"Sensorineural hearing impairment","primary":false},{"hpoId":"HP:0000763","label":"Sensory neuropathy","primary":false},{"hpoId":"HP:0001258","label":"Spastic paraplegia","primary":false},{"hpoId":"HP:0012511","label":"Temporal optic disc pallor","primary":false}],"ledeHtml":"Autosomal dominant optic atrophy plus syndrome (ADOA plus) is a rare syndrome that causes vision loss, hearing loss, and symptoms affecting the muscles. The syndrome is associated with degeneration of the optic nerve (optic atrophy). The optic nerve sends signals about what the eyes are seeing to the brain. When there is optic nerve damage, it causes vision loss. Other symptoms of ADOA plus include sensorineural hearing loss and symptoms affecting the muscles such as muscle pain and weakness. ADOA plus is caused by changes in the OPA1 gene. The syndrome is inherited in an autosomal dominant manner. A diagnosis of ADOA plus is suspected when an eye exam finds degeneration of the optic nerve (optic atrophy). The diagnosis can be confirmed with a muscle biopsy and genetic testing of the OPA1 gene.","mondoId":"MONDO:0014720","node":{"canonicalSlug":"autosomal-dominant-optic-atrophy-plus","comparisons":[{"documentSha256":"9a5cd809b86761cb854f2a97f6c9717dd58f34db8e2e63b33e0c399e44b9e57b","key":"legacy-autosomal-dominant-optic-atrophy-plus","kind":"legacy","label":"autosomal dominant optic atrophy plus syndrome","memberIds":["MONDO:0007429","MONDO:0008131","MONDO:0011038","MONDO:0014720","MONDO:0024569"],"mondoId":"MONDO:0014720","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/autosomal-dominant-optic-atrophy-plus.9a5cd809b86761cb854f2a97f6c9717dd58f34db8e2e63b33e0c399e44b9e57b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal dominant optic atrophy plus syndrome","originalSourceId":"ORPHA:1215","paragraphs":["Autosomal dominant optic atrophy plus syndrome (ADOA plus) is a rare syndrome that causes vision loss, hearing loss, and symptoms affecting the muscles. The syndrome is associated with degeneration of the optic nerve (optic atrophy). The optic nerve sends signals about what the eyes are seeing to the brain. When there is optic nerve damage, it causes vision loss. Other symptoms of ADOA plus include sensorineural hearing loss and symptoms affecting the muscles such as muscle pain and weakness. ADOA plus is caused by changes in the OPA1 gene. The syndrome is inherited in an autosomal dominant manner. A diagnosis of ADOA plus is suspected when an eye exam finds degeneration of the optic nerve (optic atrophy). The diagnosis can be confirmed with a muscle biopsy and genetic testing of the OPA1 gene."],"rawAttribution":"MONDO:0014720","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T15:51:03Z","upstream":"GARD:0005243","url":"https://rarediseases.info.nih.gov/diseases/5243"},"ownColumnKeys":["population-3abb8c6fa526ba0853a5"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal dominant disease","mondoId":"MONDO:0000426","slug":null},{"kind":"parent","label":"hereditary optic atrophy","mondoId":"MONDO:0043878","slug":"hereditary-optic-atrophy"},{"kind":"parent","label":"mitochondrial disease","mondoId":"MONDO:0044970","slug":null},{"kind":"child","label":"optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy","mondoId":"MONDO:0007429","slug":"optic-atrophy-with-or-without-deafness-ophthalmoplegia-myopathy-ataxia-and-neuropathy"},{"kind":"child","label":"optic atrophy, hearing loss, and peripheral neuropathy, autosomal dominant","mondoId":"MONDO:0008131","slug":"optic-atrophy-hearing-loss-and-peripheral-neuropathy-autosomal-dominant"},{"kind":"child","label":"cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome","mondoId":"MONDO:0011038","slug":"cerebellar-ataxia-areflexia-pes-cavus-optic-atrophy-sensorineural-hearing-loss"},{"kind":"child","label":"optic atrophy 8","mondoId":"MONDO:0024569","slug":"optic-atrophy-8"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0473c1ec178f4e1b1737b4d33b59711663fd806ad910c63b13e854e1235bad36","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000407","is_excluded":false,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0e61860dfe83083f278e949c416cb8ee12c52e774418a45edd9983a914770327","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000529","is_excluded":false,"label":"Progressive visual loss","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"27b3707c21fd531cc407239943fe1c76a9b407ce5b6fc4e93d09f1a6d7f2c789","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100285","is_excluded":false,"label":"EMG: impaired neuromuscular transmission","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"33a364533972607574ab8e1c0d220b3fc8331a63b81acadcc81622e3e160c494","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003444","is_excluded":false,"label":"EMG: chronic denervation signs","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"350526a4dbef0804268536a2f35fbafa70b84ccba9c959f64966187f06ceb405","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0020119","is_excluded":false,"label":"Abnormal retinal nerve fiber layer morphology","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"367c6f0fcc55f6dc083222ffdb3ecd244359e85e3f885b2afce26d3170a1063f","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000649","is_excluded":false,"label":"Abnormality of visual evoked potentials","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3bbf5c08c123e7df149a9bae91fb04ecc696ec28d43c3fdb13042713ffb954df","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"40994de43315357426542f1df37f9708ae171420da4b27520b6d05c2557762b2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4631bd238b65c244d4ef71dcac96f2df0e8f826834cb117fdb59c0902106fb0a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001761","is_excluded":false,"label":"Pes cavus","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4aa5a09fa569fe4a52fc1bf45346456698f5dc4f8c796962c28bb5e52a2819b8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004463","is_excluded":false,"label":"Absent brainstem auditory responses","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"54d10b2a3caaccb62948533bd9726fb01a918ad248bc4943059e8afa74212ca2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000763","is_excluded":false,"label":"Sensory neuropathy","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5b5d78112382431b5a12f210bad6d8de86b6ae63ee80fc96de72fbe309809211","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001133","is_excluded":false,"label":"Constriction of peripheral visual field","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6691323d105999ab47c5c34af8d860fc12de29b5b14b0c04d14bbe99d9128c5a","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001488","is_excluded":false,"label":"Bilateral ptosis","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6a042c6c9a89b789161bba2a282d406bcec187a87d62d044010b9d60f4cc2341","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001258","is_excluded":false,"label":"Spastic paraplegia","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f132c57cc40b31b032269b3940ad3c3dd5f80f46c4f387002801976b1251de2","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012511","is_excluded":false,"label":"Temporal optic disc pallor","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"76a1d604409dd78b85653d41e0c0cd03befdea15d73b5e7408bc8f79e03f9bbf","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"77b7b7b86f94088c3ab3c4ead467d40a7efb71072fd0137eaaa7e0d848fb6c8f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003325","is_excluded":false,"label":"Limb-girdle muscle weakness","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"adc9fe72e50441de8770f39e8420b6feadcfc202668de86270331dab4f85ab2a","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000590","is_excluded":false,"label":"Progressive external ophthalmoplegia","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"af354b8e08cc79c2a8072eb517859e3c8f5549c40878763e5d3ba8f084806643","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b5b41ee4361cbb9d919eadab81b8c1bb3e2305296733cd46af0443a62f59e431","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002076","is_excluded":false,"label":"Migraine","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc0e68b6e878be5e888ed0e1a6069e24d9cbed96c45ca2716d63bc47687ce96e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"be5675860649520d345f447adec2ec43c1e035921bf08b34e83a1adaeadfb149","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003438","is_excluded":false,"label":"Absent Achilles reflex","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c49669daa48f65138a7cbc2fe1c82adf4fd05bb2696bc0ed09db78d0274d26fa","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c991b5091478b9fa0d1616921d2ccc751c4a865f443113954593af279d35ba75","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f337aff3f68b7ff908ad02bee155635bdb68deb9c8fa84ed7441d2caa6e5d6f2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007002","is_excluded":false,"label":"Motor axonal neuropathy","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f55e760c03b5b1e34ccfb2b8f9eaf3367a9cf0f5cb22572db6b5941debbfa444","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1215","disease_name":"Autosomal dominant optic atrophy plus syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003737","is_excluded":false,"label":"Mitochondrial myopathy","onset_id":null,"reference":"ORPHA:1215","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5243\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014720\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0005243</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Autosomal dominant optic atrophy plus syndrome (ADOA plus) is a rare syndrome that causes vision loss, hearing loss, and symptoms affecting the muscles. The syndrome is associated with degeneration of the optic nerve (optic atrophy). The optic nerve sends signals about what the eyes are seeing to the brain. When there is optic nerve damage, it causes vision loss. Other symptoms of ADOA plus include sensorineural hearing loss and symptoms affecting the muscles such as muscle pain and weakness. ADOA plus is caused by changes in the OPA1 gene. The syndrome is inherited in an autosomal dominant manner. A diagnosis of ADOA plus is suspected when an eye exam finds degeneration of the optic nerve (optic atrophy). The diagnosis can be confirmed with a muscle biopsy and genetic testing of the OPA1 gene.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5243\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-dominant-optic-atrophy-plus","sourceDocuments":[{"name":"GARD: Autosomal dominant optic atrophy plus syndrome","reviewed":null,"source_release":"2026-10-21T15:51:03Z","url":"https://rarediseases.info.nih.gov/diseases/5243"},{"name":"MONDO: autosomal dominant optic atrophy plus syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014720"}],"sourceNote":"","synonyms":["DOA+","dominant optic atrophy, deafness, ptosis, ophthalmoplegia, dystaxia, and myopathy","optic atrophy - deafness- polyneuropathy - myopathy","optic atrophy-deafness-polyneuropathy-myopathy syndrome","Treft-Sanborn-Carey syndrome"],"takeawayHtml":"","title":"autosomal dominant optic atrophy plus syndrome"},"schemaVersion":1}
